CARCINOMA OF PANCREAS
CARCINOMA OF PANCREAS
- Carcinoma of pancreas is the 4th leading cause of cancer in males.


RISK FACTORS-
- Demographic, environmental factor
- Smoking/ tobacco
- Obesity
- Exposure to benzidine, DDT
2. Molecular carcinogenesis
- MC mutation- KRAS
- MC inactivated tumour suppression gene- p16/ CDKN2A
3. Genetic and medication factors-
- Hereditary pancreatitis
- Chronic pancreatitis
- Peutz- Jegher’s syndrome (MC risk), Gardner’s syndrome
- HNPCC
- Ataxia telangiectasia
- Familial breast- ovarian cancer syndrome
- DM
- Hemochromatosis
PATHOLOGY-
- Periampullary refers to carcinoma arising from ampulla of Vater, duodenal mucosa or lower end of common bile duct.
- MC tumour of pancreas is ductal adenocarcinoma with the most common site being the head of the gland.
- Cystic tumours are mucinous and serous
a) Serous cystadenomas are benign seen in older women.
b) Mucinoustumors- have malignant potential. They are-
i) Mucinous cystic neoplasm (MCN)
- Occurs in perimenopausal women
- Present in pancreatic body or tail
- It contains histologically ovarian type stroma
ii) Intraductal papillary mucinous neoplasm (IPMN)
- Seen in old men
- Common in pancreatic head
- More tendency to be malignant.

- Proliferative lesion in the pancreatic ducts –> invasive ductal adenocarcinoma termed as pancreatic intraepithelial neoplasm or PanIN.
- Solid pseudopapillary tumours are rare malignancy seen in childbearing age women.

CLINICAL FEATURES-
- MC site- head> body > tail
- Seen in 6th to 7th decade
- More common in males
- Prognosis is bad
- Nausea vomiting, weight loss and abdominal pain
- Back pain (retroperitoneal infiltration)
- Jaundice (MC)
- Trousseau’s sign (thrombophelbitis migrans)
- Migrating thrombophelibitis of the legs occurs in visceral malignancies
- It is superficial and affects the leg veins
- Anaemia
- Hard, irregular fixed mass
- Duodenal obstruction

INVESTIGATIONS-
- Pancreatic head tumors – contrast enhanced CT
- ERCP is the most sensitive test for detecting pancreatic cancer but CT scan is the inv. of choice.
2. USG- first IOC
- Detects a tumor
- Diagnois required prior to surgery
3. CA 19- 9 (carbohydrate antigen)
- Increase in 80% tumors
- Tumour marker of pancreas to detect Pancreas carcinoma
4. ERCP- small ampullary lesion
- Double duct sign
- Scrambled egg appearance
5. Barium meal X-ray
- Rose thorn appearance in hypotonic duodenography
- Reverse 3 sign- periampullary carcinoma
- Pad sign (widened C loop of duodenum) – carcinoma head

TREATMENT-
- Carcinoma head of pancreas (ampulla)-
- Pylorous preserving pancreatico
- Duodenectomy
- Whipple’s procedures
2. Carcinoma of body/ tail
- Distal pancreatomy with en- bloc splenectomy
- Multifocal tumor- total pancreatectomy (main duct IMPN)
- Radiotherapy
- Gemcitabine + erlobinib- HER1/ EGFR tyrosine kinase inhibitor for metastatic disease
- Stage wise survival after treatment-
a) Stage I and II- 16- 20 months
b) Stage III- 6- 10 months
c) Stage IV- 3- 6 months
Exam Important
RISK FACTORS-
- Demographic, environmental factor
- Smoking/ tobacco
- Obesity
- Exposure to benzidine, DDT
2. Molecular carcinogenesis
- MC mutation- KRAS
- MC inactivated tumour suppression gene- p16/ CDKN2A
3. Genetic and medication factors-
- Hereditary pancreatitis
- Chronic pancreatitis
- Peutz- Jegher’s syndrome (MC risk), Gardner’s syndrome
- HNPCC
- Ataxia telangiectasia
- Familial breast- ovarian cancer syndrome
- DM
- Hemochromatosis
CLINICAL FEATURES-
- MC site- head> body > tail
- Seen in 6th to 7th decade
- More common in males
- Prognosis is bad
- Nausea vomiting, weight loss and abdominal pain
- Back pain (retroperitoneal infiltration)
- Jaundice (MC)
- Trousseau’s sign (thrombophelbitis migrans)
- Migrating thrombophelibitis of the legs occurs in visceral malignancies
- It is superficial and affects the leg veins
- Anaemia
- Hard, irregular fixed mass
- Duodenal obstruction
INVESTIGATIONS-
- Pancreatic head tumors – contrast enhanced CT
- ERCP is the most sensitive test for detecting pancreatic cancer but CT scan is the inv. of choice.
2. USG- first IOC
- Detects a tumor
- Diagnois required prior to surgery
- Stage wise survival after treatment-
a) Stage I and II- 16- 20 months
b) Stage III- 6- 10 months
c) Stage IV- 3- 6 months
Don’t Forget to Solve all the previous Year Question asked on CARCINOMA OF PANCREAS
Click Here to Start Quiz
Click Here to Start Quiz


